Flutemetamol Completed Phase 2 Trials for Alzheimer's Disease (AD) / Healthy Subjects (HS) / Mild Cognitive Impairment (MCI) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT02813070Comparison of PET Amyloid Imaging in Japanese and Western Subjects